Ami Organics Ltd
AMIORGAmi Organics Ltd
AMIORG


Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
84.09 | 14.95 | 0.11% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.09 | 6.50 | 0.52% |
Forecast & Ratings
Detailed Forecast from 5 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
AMI Organics is a manufacturer of pharmaceutical preparation.
Investor Presentation
View olderPeers
Compare with peersGet more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 156.57 | 160.47 | 191.18 | 238.89 | 242.48 | 341.99 | 522.90 | 621.05 | 724.96 | 935.84 | ||||||||||
Raw Materials | 93.58 | 94.75 | 114.72 | 151.95 | 137.96 | 174.87 | 282.33 | 345.85 | 440.17 | 733.40 | ||||||||||
Power & Fuel Cost | 1.26 | 1.00 | 1.27 | 4.14 | 4.54 | 5.26 | 21.40 | 22.28 | 25.82 | |||||||||||
Employee Cost | 7.02 | 7.38 | 9.89 | 8.54 | 12.95 | 21.01 | 41.37 | 48.84 | 63.11 | |||||||||||
Selling & Administrative Expenses | 22.60 | 17.60 | 12.56 | 14.77 | 15.38 | 12.13 | 27.34 | 36.69 | 33.12 | |||||||||||
Operating & Other expenses | 11.05 | 16.40 | 19.26 | 17.03 | 27.79 | 47.18 | 42.51 | 40.46 | 58.85 | |||||||||||
EBITDA | 21.06 | 23.34 | 33.48 | 42.46 | 43.86 | 81.54 | 107.95 | 126.93 | 103.89 | 202.44 | ||||||||||
Depreciation/Amortization | 0.80 | 1.37 | 1.91 | 2.60 | 3.52 | 4.19 | 10.08 | 12.34 | 16.06 | 24.23 | ||||||||||
PBIT | 20.26 | 21.97 | 31.57 | 39.86 | 40.34 | 77.35 | 97.87 | 114.59 | 87.83 | 178.21 | ||||||||||
Interest & Other Items | 2.56 | 3.30 | 3.23 | 4.75 | 5.59 | 5.62 | 6.41 | 2.41 | 5.94 | 7.69 | ||||||||||
PBT | 17.70 | 18.67 | 28.34 | 35.11 | 34.75 | 71.73 | 91.46 | 112.18 | 81.89 | 170.52 | ||||||||||
Taxes & Other Items | 5.05 | 6.63 | 9.86 | 11.81 | 7.29 | 17.72 | 19.50 | 28.88 | 39.14 | 49.15 | ||||||||||
Net Income | 12.65 | 12.04 | 18.48 | 23.30 | 27.46 | 54.01 | 71.96 | 83.30 | 42.75 | 121.37 | ||||||||||
EPS | 4.02 | 3.82 | 5.87 | 7.40 | 8.72 | 17.15 | 21.18 | 22.86 | 11.66 | 32.91 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 3.00 | 3.00 | 3.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.13 | 0.26 | 0.09 |
Company Updates
Investor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Ami Organics Ltd | 238.73 | 14.95 | 0.11% |
Sun Pharmaceutical Industries Ltd | 43.84 | 6.26 | 0.77% |
Cipla Ltd | 28.85 | 4.44 | 0.88% |
Torrent Pharmaceuticals Ltd | 66.58 | 16.09 | 0.86% |
Price Comparison
Compare AMIORG with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 1.13%
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 1.65%
Shareholding Pattern
May 2024
Jun 2024
Sep 2024
Dec 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Ami Organics Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.7165% | Percentage of the fund’s portfolio invested in the stock 0.97% | Change in the portfolio weight of the stock over the last 3 months 0.12% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 64/85 (+3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.8342% | Percentage of the fund’s portfolio invested in the stock 1.90% | Change in the portfolio weight of the stock over the last 3 months 0.31% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 42/67 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2271% | Percentage of the fund’s portfolio invested in the stock 3.56% | Change in the portfolio weight of the stock over the last 3 months 0.30% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/33 (+2) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 13, 2024
Dividend/Share
₹3.00
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 18, 2023
Dividend/Share
₹3.00
Ex DateEx Date
Sep 18, 2023
Cash Dividend
Ex DateEx DateJul 29, 2022
Dividend/Share
₹3.00
Ex DateEx Date
Jul 29, 2022
Revenue from operations jumped 65.21% to Rs 274.98 crore in Q3 FY25 as compared with Rs 166.44 crore in Q3 FY24. Total expenses grew by 45.87% YoY to Rs 213.32 crore during the quarter. Employee benefit expenses was at Rs 21.66 crore (up 34.28% YoY). The cost of material consumed stood at Rs 157.21 crore (up 82.52% YoY). Profit before tax stood at Rs 633.34 crore in Q3 FY25, marking a growth of 167.19% as against Rs 237.03 crore posted in Q3 FY24. EBITDA stood at Rs 68.70 crore in Q3 FY25, recording the growth of 159.24% as compared with Rs 26.50 crore in Q3 FY24. EBITDA margin improved by 25% during the quarter as compared with 15.9% posted in the corresponding quarter last year. Naresh Patel, executive chairman & MD, Ami Organics, said: I am delighted to share that in the first nine months of FY25, we achieved revenue of X698 crore, nearly equalling the revenue from operations of the entire previous financial year. In Q3FY25 alone, we delivered an impressive 65.2% year-on-year growth, achieving X275 crore in revenue from operations. This performance was driven by a strong ramp-up in our CDMO business and consistent growth in advanced pharmaceutical intermediates. Our pipeline of CDMO projects is progressing well, with several initiatives nearing commercialization by FY26, solidifying the foundation for sustained long-term growth. Ongoing discussions with innovators and partners remain highly encouraging, and we are confident that the CDMO segment will see exponential growth in the coming years. With improved visibility for Q4, I am pleased to revise our FY25 growth guidance upward from 30% to 35%. This milestone reflects our unwavering commitment to delivering consistent progress, embracing adaptability, and seizing new opportunities that ensure sustainable and impactful growth.' Ami Organics is engaged in the business of drugs, intermediate chemicals, and related activities. Powered by Capital Market - Live
Net profit of Ami Organics rose 168.36% to Rs 44.95 crore in the quarter ended December 2024 as against Rs 16.75 crore during the previous quarter ended December 2023. Sales rose 65.22% to Rs 274.99 crore in the quarter ended December 2024 as against Rs 166.44 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales274.99166.44 65 OPM %24.9715.93 - PBDT69.6527.46 154 PBT63.3323.70 167 NP44.9516.75 168 Powered by Capital Market - Live
AMI Organics will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live
Net profit of Ami Organics reported to Rs 37.33 crore in the quarter ended September 2024 as against net loss of Rs 18.85 crore during the previous quarter ended September 2023. Sales rose 43.15% to Rs 246.73 crore in the quarter ended September 2024 as against Rs 172.36 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales246.73172.36 43 OPM %19.8314.39 - PBDT56.8725.50 123 PBT50.0421.81 129 NP37.33-18.85 LP Powered by Capital Market - Live
Ami Organics has allotted 6,950 equity shares under ESOS on 14 October 2024. Pursuant to this allotment, the paid up share capital of the Company stands increased from Rs. 40,92,75,110/- (consisting of 4,09,27,511 equity shares of face value of Rs. 10/-each) to Rs. 40,93,44,610/- (consisting of 4,09,34,461 equity shares of face value of Rs. 10/- each). Powered by Capital Market - Live
AMI Organics announced that the Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
AMI Organics announced that the Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
Ami Organics has allotted 21,950 equity shares under ESOS. Pursuant to the allotment, the paid up equity share capital has increased to Rs. 40,92,75,110/- (consisting of 4,09,27,511 equity shares of face value of Rs. 10/- each). Powered by Capital Market - Live
Net profit of Ami Organics declined 29.26% to Rs 13.95 crore in the quarter ended June 2024 as against Rs 19.72 crore during the previous quarter ended June 2023. Sales rose 14.93% to Rs 176.67 crore in the quarter ended June 2024 as against Rs 153.72 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales176.67153.72 15 OPM %16.7122.12 - PBDT26.1334.65 -25 PBT19.9530.94 -36 NP13.9519.72 -29 Powered by Capital Market - Live
AMI Organics will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 24.86%, vs industry avg of 9.04%
Increasing Market Share
Over the last 5 years, market share increased from 0.11% to 0.19%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 12.91%, vs industry avg of 15.28%